# Quality of Life Comparison in Advanced Non-squamous Non Small Cell Lung Cancer

> **NCT01303926** · PHASE3 · UNKNOWN · sponsor: **Gruppo Oncologico Italia Meridionale** · enrollment: 118 (estimated)

## Conditions studied

- Non-squamous Nonsmall Cell Neoplasm of Lung

## Interventions

- **DRUG:** cisplatin pemetrexed
- **DRUG:** carboplatin paclitaxel bevacizumab

## Key facts

- **NCT ID:** NCT01303926
- **Lead sponsor:** Gruppo Oncologico Italia Meridionale
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-01
- **Primary completion:** 2012-06
- **Final completion:** 2012-06
- **Target enrollment:** 118 (ESTIMATED)
- **Last updated:** 2012-04-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01303926

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01303926, "Quality of Life Comparison in Advanced Non-squamous Non Small Cell Lung Cancer". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT01303926. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*